Description
Enclomiphene Citrate + 6-OXO Capsules
The Enclomiphene Citrate + 6-OXO Capsules contain two research compounds. Each has unique biological properties that scientists study in labs. This stack is for research use only. It is not approved for human or animal consumption.
What is Enclomiphene Citrate?
Enclomiphene Citrate is a selective estrogen receptor modulator (SERM). Researchers study it for its potential effects on hormone regulation in lab models. It is a trans-isomer of clomiphene.
Mechanism of Action
Enclomiphene Citrate may bind to estrogen receptors in the hypothalamus. This action blocks estrogen's negative feedback on the hypothalamic-pituitary-gonadal axis. As a result, luteinizing hormone (LH) levels may increase in lab studies. Follicle-stimulating hormone (FSH) levels may also rise in the same studies.
These changes may support the study of testosterone production in research models.
What is 6-OXO?
6-OXO is investigated as a potential aromatase inhibitor. It may reduce the conversion of androgens to estrogens in lab studies, though its potency is weaker compared to pharmaceutical aromatase inhibitors.
Mechanism of Action
6-OXO binds to the aromatase enzyme, which may normally convert androgens into estrogen. By inhibiting this enzyme, 6-OXO may reduce estrogen synthesis. Research shows this can alter the androgen-to-estrogen ratio in lab models.
Possible Research Applications
The Enclomiphene Citrate + 6-OXO Capsules may be studied for:
- Hormone regulation in lab models
- Effects on testosterone and estrogen balance in lab studies
- Potential synergy in supporting hormonal pathways for research purposes
- Comparative studies with other SERMs and aromatase inhibitors.
Research on Enclomiphene Citrate + 6-OXO
In preclinical studies, both compounds have been examined individually and in combination:
- Enclomiphene Citrate Studies: Research models show stimulation of the hypothalamic-pituitary-gonadal axis. These studies also suggest potential increases in LH and FSH.
- 6-OXO Studies: Lab models indicate reduced aromatase activity. This may lead to lowered estrogen levels and changes in hormonal profiles.
- Combination Studies: The combination is investigated for its potential to influence testosterone and estrogen balance in research models, but no clinical trials confirm these effects. This makes it of interest for hormone balance research, though its role remains investigational.
Key Points
- High-purity reference formulation
- Combines a SERM and aromatase inhibitor for broad research applications
- Designed for laboratory and research use only.
Where to buy Enclomiphene Citrate + 6-OXO Capsules online for research purposes?
If you are looking to buy Enclomiphene Citrate + 6-OXO Capsules for laboratory use, PureRawz provides high-quality reference materials.
Each product comes with a Certificate of Analysis for verification of purity and concentration.
Is Enclomiphene Citrate + 6-OXO Capsules legal?
The legal status varies by jurisdiction. Enclomiphene is not FDA-approved, and 6-OXO has restrictions in some regions. These compounds are supplied for research purposes only.
Disclaimer
This information is for educational purposes only and not medical advice. Products are for research use only. Research must follow IRB or IACUC guidelines. Verify information independently before purchasing. By ordering, you agree to our Terms and Conditions. If you are not 100% satisfied with the product you received, please contact us at support@staging.purerawz.co
ATTENTION: All our products are strictly for LABORATORY AND RESEARCH PURPOSES. They are not intended for human or veterinary use.
Dr. Helma Wennemers
Dr. Helma Wennemers is a globally recognized chemist shaping modern peptide science and molecular design through highly original research in applied biosciences.
Her work explores how precise molecular architecture can be engineered to create new functional systems in chemistry and life sciences. Her contributions continue to redefine contemporary chemical research through creativity, depth, and structural innovation.

